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Abstract 
Background 
Multimorbidity is recognised internationally as having a serious impact on health outcomes. 
It is associated with reduced quality of life, increased healthcare utilisation and future 
functional decline.  Physical activity is associated with good health and psychological well-
being. The aim of this study was to identify the impact of physical activity and physical 
function on the development and worsening of multimorbidity over time. 
Methods 
Using The Irish Longitudinal Study on Ageing (TILDA), we analysed 4,823 participants >50 
years with and without multimorbidity. Multimorbidity was defined as the presence of ≥2 
chronic conditions. Development of multimorbidity was measured as the accrual of additional 
conditions over a two year period. Physical activity and physical function were measured 
using the International Physical Activity Questionnaire (IPAQ), gait speed (m/sec) and grip 
strength (kg).  
Results 
Sixteen groups of chronic conditions were included in analyses. 53.7% of included 
participants had multimorbidity at baseline and 71.7% at follow up.  638/2092 (30.4%) 
participants without multimorbidity and 1005/2415 (41.6%) with existing multimorbidity 
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developed new condition/s. Gait speed (RR=0.67, CI:0.49-0.90), grip strength (RR=0.98, 
CI:0.97-0.99) and age (compared to 50-59 years, 60-69: RR=1.30, CI:1.11-1.52; ≥70: 
RR=1.35, CI:1.03 – 1.77) were significantly associated with development of multimorbidity 
and accrual of additional conditions.  
Conclusion  
These results show that physical function is associated with the development and worsening 
of multimorbidity over time. They support the recent National Institute for Health & Care 
Excellence (NICE) Guidance on multimorbidity that suggests that patients with 
multimorbidity and reduced gait speed should be identified and targeted for interventions to 
improve health outcomes. 
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Background 
Average life expectancy is rising worldwide with increasing numbers of people living with 
multiple chronic medical conditions. Multimorbidity, commonly defined as the co-occurrence 
of two or more chronic medical conditions in an individual [1], affects up to one quarter of 
primary care populations [2, 3]. Higher prevalence is associated with socioeconomic 
deprivation and ageing [2]. It is associated with reduced quality of life, increased healthcare 
utilisation and an increased risk of mental health difficulties [1, 2, 4]. Complex 
multimorbidity, defined as three or more chronic conditions affecting three or more body 
systems can be especially challenging with higher healthcare utilization and polypharmacy 
[5]. Management of multimorbidity is a major challenge for health systems globally. It has 
been reported that one third of all consultations in general practice in the United Kingdom are 
for patients with more than one chronic condition [6].  
The World Health Organization estimates that approximately 3.2 million deaths each year are 
attributable to insufficient physical inactivity [7]. Older adults who are more physically active 
have lower rates of cardiovascular disease, cancer and all-cause mortality along with 
improved cognition and reduced risk of falling [7]. Physical activity prevents or reduces 
functional decline [8, 9]. The existing literature examining the association between 
multimorbidity and physical activity has demonstrated mixed results with two studies 
findings an association [10, 11] and two reporting no link [12, 13]. However, these studies 
were all cross-sectional in design and did not assess the trends in multimorbidity over time. 
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One previous longitudinal study investigated the prevalence of multimorbidity over time by 
levels of physical activity and identified an inverse dose-response relationship in that the 
odds of multimorbidity were lower in those who were physically active compared to those 
who were physically inactive [14]. This study included refreshment samples at different time-
points which may have affected estimates and the only outcome measure used was a study 
specific self-reported measure of physical activity.  
Poor physical functioning is also linked to adverse health outcomes [15] and is addressed by 
the WHO’s International Classification of Functioning, Disability and Health (ICF) [16]. 
Grip strength and gait speed assessments are reliable measures of physical function [17]. Grip 
strength has been reported to predict accelerated dependency in activities of daily living and 
cognitive decline in older people [18]. Gait speed has been described as the sixth vital sign 
and labelled as a principal indicator of health and is n inexpensive, reliable measure of 
physical function [19]. 
We previously conducted a systematic review which demonstrated that multimorbidity is 
associated with poorer function and with future functional decline. The review indicated that 
there is greater functional decline in patients with higher numbers of conditions and greater 
disease severity [20]. It is not known whether the effect also occurs in the opposite direction 
i.e. do poor levels of physical activity and function lead to the development of 
multimorbidity? Determining the impact of levels of physical activity and physical function 
on multimorbidity development will inform healthcare providers and aid the design of 
appropriate interventions that can improve health outcomes and reduce health care costs.   
The primary aim of this study was to assess the impact of physical activity and function on 
the development of multimorbidity over a two year period in an older population without 
multimorbidity at baseline. Secondary aims were to assess the impact of physical activity and 
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function on the worsening of multimorbidity over a two year period in a population of older 
adults with established multimorbidity and in those with complex multimorbidity at baseline. 
 
Methods 
Study design 
We completed secondary analysis of a longitudinal cohort study. The strengthening the 
reporting of observational studies in epidemiology (STROBE) guidelines were utilised in the 
conduct and reporting of this study [21]. 
Data source and study population  
The Irish Longitudinal Study on Ageing (TILDA) is a population based cohort study 
assessing health, economic and social aspects of ageing in the Republic of Ireland. TILDA is 
a nationally representative study of 8,175 community-dwelling residents aged 50 years and 
older [22]. This study is an analysis of the first (2010) and second (2012) waves of TILDA. 
At Wave 1 participants completed a computer-assisted personal interview in their own home 
and subsequently were invited to attend a health centre for a comprehensive health 
assessment. Ethical approval for TILDA was obtained from the Trinity College Dublin 
Research Ethics Committee.  
Included conditions 
Thirty individual chronic conditions were included in analyses. The thirty chronic conditions 
were chosen by TILDA as of their public health significance and their prevalence in those > 
50 years [23]. These conditions were consolidated to sixteen chronic conditions or groups of 
conditions: cardiac conditions; cerebrovascular disease; hypertension; diabetes; high 
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cholesterol; chronic respiratory disease; liver disease; eye disease; cognitive impairment; 
arthritis; osteoporosis; cancer; Parkinson’s disease; emotional /psychological condition; 
stomach ulcers; varicose veins (Appendix A).  
Multimorbidity was defined as two or more chronic conditions in the one individual. The 
study participants were grouped into two categories: no multimorbidity (zero or one 
condition) n=2,235 and established multimorbidity (two or more conditions) n=2,588 at 
Wave 1. These groups of participants were followed to Wave 2. Development of 
multimorbidity and worsening of multimorbidity was measured by accrual of new condition/s 
between Wave 1 and Wave 2. In addition, we completed a sub-group analysis, following 
participants with complex multimorbidity (>3 chronic conditions) n=2415 at baseline to 
Wave 2.  
Measures of physical activity and function  
Levels of physical activity and function were assessed using three validated outcome 
measures: the International Physical Activity Questionnaire (IPAQ), gait speed and grip 
strength [22, 24]. The IPAQ is a self-reported measure and gait speed and grip strength are 
performance-based assessments. Only study participants with complete data recorded on all 
three measures were included (Figure 1).  
Physical activity was measured using the short form of the IPAQ [25]. Each participant was 
classified as having High, Moderate or Low activity levels based on agreed criteria [26].  
Grip strength was measured using a grip dynamometer, two measures of handgrip strength 
were taken from the dominant hand and the mean of these readings was calculated. Gait 
speed was measured using the GAITRite portable electronic walkway system [24]. 
Participants performed two walks at their usual pace along a 4.88m (16ft) walkway. They 
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started and finished walking 2.5m before and 2m after the walkway to allow for acceleration 
and deceleration.  The two walks were combined and the average gait speed was calculated.   
 
Statistical analysis   
A modified Poisson regression analysis with robust error variances was used to determine the 
relationship between levels of physical activity and function with both the development of 
multimorbidity and worsening of multimorbidity. Binary outcomes in cohort studies are 
commonly analysed using a logistic regression model to obtain odds ratios. However, in 
order to estimate and report relative risks and confidence intervals, we used a modified 
Poisson regression analysis with robust error variances.  
Confounders and covariates 
Age and sex were included in the models as covariates. To make analysis comparable to other 
similar studies age was categorised in ten year age bands; 50-59 years; 60-69 years; ≥70 
years [2, 13]. Additional confounders included in the analysis were education level, body 
mass index (BMI) and smoking (smoker, non-smoker). Participants deemed as underweight 
(0.5%), were merged with the normal category for BMI. The presence of state financial 
support for healthcare was used as a proxy for socioeconomic status. Measurement for each 
of the variables has been described previously [22, 24, 26].  
Results are presented as adjusted relative risks (RR) with associated 95% confidence intervals 
(CI). P-values <0.05 were deemed significant. All analyses were conducted using Stata 
Version 13.0 (Stata Statistical Software: Release 13. College Station, TX: StataCorpLP).  
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Characteristics of the sample  
Included participants (n=4823) are presented in Figure 1. The characteristics of the study 
population are displayed in Table 1. At Wave 1, 2235 (46.3%) participants did not have 
multimorbidity and 2588 (53.7%) had multimorbidity. The two groups were significantly 
different in all categories at baseline (Table 1). We completed a test of gender interaction and 
there was no significant difference between male and females and thus no evidence to 
warrant stratifying the data by gender. Those with multimorbidity were older than those 
without multimorbidity and the majority in both groups were non-smokers and overweight or 
obese. The most common conditions in study participants were high cholesterol (41.3%), 
high blood pressure (33.6%) and arthritis (26.3%), while the prevalence of other conditions 
such as cardiac conditions, diabetes, respiratory disease, eye disease and osteoporosis varied 
from 6.1% to 16.7%. These results are in keeping with previous research which demonstrated 
high blood pressure, arthritis and cardiovascular disease to be the most prevalent conditions 
in a cohort aged 65 years or older [27].   
Development of multimorbidity 
Of the 2235 participants with no multimorbidity at baseline, 2092 (93.6%) were followed up 
two years later. By Wave 2, 638 (30.4%) had developed multimorbidity. Multivariate 
analysis demonstrated that age (compared to 50-59 years, 60-69 years: RR=1.30, 95% CI: 
1.11-1.52; ≥70 years: RR=1.35, 95% CI: 1.03 – 1.77), obesity (compared to normal and  
underweight: RR=1.26, 95% CI: 1.05-1.51), gait speed (RR=0.67, 95% CI: 0.49-0.90) and 
grip strength (RR=0.98, 95% CI: 0.97-0.99) were significantly associated with the 
development of multimorbidity. There was no evidence of an association between IPAQ and 
the development of multimorbidity (Table 2). With every one kilogramme increase in grip 
Results  
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strength, the risk of developing multimorbidity decreases. Similarly, each metre per second 
increase in gait speed decreases the risk of developing multimorbidity (Table 2).  
Worsening of multimorbidity 
Of the 2588 participants with multimorbidity at baseline, 2415 (93.3%) were followed up two 
years later. Of these, 1005 (41.6%) had developed worsened multimorbidity in Wave 2. Age 
(compared to 50-59 years, 60-69 years: RR=1.20, 95% CI: 1.07-1.34; ≥70 years: RR=1.18, 
95% CI: 1.01-1.37), access to government funded primary healthcare (RR=1.20, 95% CI: 
1.07-1.34), grip strength (RR=0.990, 95% CI: 0.982-0.998), and gait speed (RR=0.61, 95% 
CI: 0.50-0.82), were all significantly associated with worsening of multimorbidity. For every 
one kilogramme increase in grip strength the incidence of worsening multimorbidity 
decreases. For each metre per second increase in gait speed, the risk of worsening 
multimorbidity also decreases.  There was no significant association between the IPAQ and 
the worsening of multimorbidity (Table 2).  
Complex multimorbidity 
1488 participants presented with complex multimorbidity at baseline (Appendix B), 1391 of 
these participants were followed up in Wave 2. 600 of the 1391 participants (43.1%) with 
complex multimorbidity had developed a new condition/s. Gait speed (RR=0.59; 95% CI: 
0.43-0.82), and age (compared to 50-59 years, 60-69 years: RR=1.18, 95% CI: 1.02-1.36; 
≥70 years: RR=1.20, 95% CI: 1.10-1.44), were significantly associated with the development 
of new conditions but grip strength was not (Appendix C). 
Discussion 
This study presents a longitudinal analysis of multimorbidity in a nationally-representative, 
population based sample of older adults.  Over a two year follow up period, 30.4% developed 
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multimorbidity and 41.6% with multimorbidity experienced worsening multimorbidity. Gait 
speed, grip strength and increasing age were significantly associated both with the 
development of multimorbidity and the worsening of existing multimorbidity with evidence 
of a dose-response relationship.  
Grip strength is a predictor of cognitive decline, disability and contributes to increasing 
dependency in old age [18]. Our study highlighted that the stronger one’s grip strength the 
less likely new chronic conditions will develop within two years.  Gait speed assessment is 
also a valuable tool in the clinical assessment of frailty and lower gait speed is associated 
with reduced strength, power, coordination and balance [19, 28]. Our results support the 
recent NICE Multimorbidity Guidance, which recommends using gait speed as an assessment 
measure to identify those patients who require prioritised/targeted care [29]. NICE is the 
National Institute for Health Care and Excellence based in the United Kingdom. They 
provide evidence based national guidance to all stakeholders with the aim to improve health 
and social care. While our study highlighted the clinical relevance of reduced gait speed, we 
did not identify a specific cut-point at which the risk of multimorbidity increased. Further 
research in this area is needed. 
Dhalwanai et al. (2016) demonstrated an inverse dose-response association between levels of 
physical activity and multimorbidity using frequency of vigorous, moderate and mild 
physical activity [14]. They highlighted the potential that the existence of multimorbidity 
may limit physical activity, which could also have happened in our cohort. The Dhalwhani 
study had a similar definition of multimorbidity but only included 16 chronic conditions 
compared to 30 in our study. In addition the only outcome measure used was a study specific 
self-report measure which was shown to have moderate correlation with accelerometer data.  
In our study, there was no evidence that the self-reported outcome measure, the IPAQ, was 
associated with development or worsening of multimorbidity. It has been acknowledged in 
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the literature that over-reporting amounts of physical activity when completing the IPAQ is 
common, with older adults having difficulty completing it accurately [30].  The IPAQ is 
recommended for population level research, however is not intended to replace instruments 
which can be more responsive to changes in individual activity level such as gait speed. 
Comparisons with the previous cross-sectional studies (10, 11, 12, 13) is difficult due to 
different measures of physical activity, differences in study population and definitions of 
multimorbidity used. Accelerometer measurements would provide added value, however, gait 
speed and grip strength assessments are cost-effective and easily accessible measurements 
used in clinical practice.  
In keeping with the evidence that obesity has negative impacts on health outcomes, 
individuals in our study with obesity were more likely to develop multimorbidity compared 
to those of normal weight though obesity was not associated with worsening of 
multimorbidity over time. The results regarding socioeconomic status were mixed. This may 
relate to the higher prevalence of socioeconomic deprivation in those with established 
multimorbidity at baseline. These results may also relate to the measure used as it does not 
identify the most socioeconomically deprived groups within the cohort as income thresholds 
for access to government funded healthcare increases with age. Existing evidence highlights 
that, patients with higher levels of socioeconomic deprivation develop multimorbidity 
significantly earlier in life than their more affluent counterparts [2]. Dhalwanai et al. included 
socioeconomic status and BMI as confounders but did not comment whether either impacted 
on the presence of multimorbidity over time [14]. 
Strengths and Limitations 
TILDA is a nationally representative population based cohort study using validated measures 
and health assessments carried out by trained research nurses using standardised protocols 
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[24]. We included thirty different conditions in our analysis encompassing a broad range of 
conditions including mental health conditions which are commonly omitted in other studies.   
A potential limitation of this study may relate to participant characteristics. The outcome 
measures used to measure physical activity and function dictated that TILDA participants 
who did not attend the health centre assessment were excluded. It has been demonstrated that 
those who were frail or disabled or more elderly were less inclined to attend the health centre 
for assessment and thus presents a potential source of bias [22]. As with other longitudinal 
studies of ageing, all participants were required to provide written informed consent to 
participate in the study at Wave 1, this will have resulted in the exclusion of individuals with 
severe cognitive impairment. We also need to acknowledge those who were lost to follow up, 
though this was minimal with 6.6% (n=148) participants with no multimorbidity and 7.2% 
(n=173) participants with multimorbidity not available for analysis two years later. A further 
limitation is that the definition of multimorbidity used does not take into account disease 
severity. However, we did use the most commonly reported definition i.e. >2 chronic 
conditions and we also conducted analyses examining complex multimorbidity (>3 chronic 
conditions) with complex multimorbid patients having higher care needs [5]. The use of self-
reported diagnoses in the analysis may be an additional limitation. However, evidence has 
demonstrated moderate to good agreement between self-reported and physician reported 
chronic conditions among multimorbid patients [31]. A final limitation was the use of State 
financial support as a proxy for socioeconomic status. While state financial support is an 
accurate proxy for socioeconomic status in Irish people under the age of 70, over this age 
different income thresholds apply and there is nearly universal coverage for this age group. 
However the majority of our cohort (80.3%) were < 70 years. 
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With an ageing population, the management of chronic medical conditions is at the forefront 
of healthcare planning and policy. Our results have implications for clinical practice in that 
assessment of physical function and appropriate intervention may prevent an inevitable 
cascade towards poorer health outcomes. Future research should focus on the development of 
interventions which prioritise physical function for this patient group to prevent the poorer 
health outcomes and increased healthcare costs associated with multimorbidity. 
 
Key points 
 Gait speed, grip strength and increasing age were shown to be significantly associated 
with the development of multimorbidity and the worsening of existing 
multimorbidity. 
 Faster gait speed and stronger grip strength were found to be associated with a 
reduced risk of developing new conditions. 
 Poor levels of physical function, as measured by grip strength and gait speed lead to 
the worsening of multimorbidity over time. 
 These results support the NICE Multimorbidity Guidance (2016), which recommends 
using gait speed as an assessment measure to identify those patients who require 
prioritised/targeted care. 
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Table 1: Baseline characteristics of study participants    
 No multimorbidity 
0/1 condition 
n= 2235 (46.3%) 
 
Multimorbidity 
2/more conditions 
n= 2588 (53.7%) 
p-value 
 
Age                                               50-59  
                                                      60-69 
                                                      70 + 
                                         
1282 (57.4%) 
697 (31.2%) 
252 (11.3%) 
 
893 (34.5%) 
995 (35.4%) 
696 (26.9%) 
 
 
<0.001 
(c) 
Sex                                             Male 
                                                   Female 
1115 (49.9%) 
1120 (50.1%) 
 
1106 (42.7%) 
1482 (57.3%) 
 
<0.001  
(c) 
Education                        Primary/ none 
                                        Secondary  
                                        Third/ higher  
                             
401 (17.9%) 
1003 (44.9%) 
830 (37.1%) 
 
653 (25.2%) 
1008 (38.9%) 
926 (35.8%) 
 
 
<0.001  
(c) 
Body Mass 
Index              Underweight (< 18.5)   
(kg/m
2
)           Normal (18.5 -25) 
                       Overweight (25.1 -30) 
                       Obese (>30.1)  
               
 
12 (0.5%) 
566 (25.3%) 
1021 (45.7%) 
634 (28.4%) 
 
 
9 (0.3%) 
518 (20.0%) 
1097 (42.4%) 
963 (37.2%) 
 
 
 
<0.001  
(c)  
Smoking Status                  Non-smoker  
                                           Smoker 
                             
1865 (83.5%) 
370 (16.5%) 
 
2244 (86.7%) 
344 (13.3%) 
 
 
0.001 
(c) 
State support 
No medical/General Practitioner card 
Medical/General Practitioner card 
                         
 
1628 (78.8%) 
605 (27.1%) 
 
 
1338 (51.7%) 
1249 (48.3%) 
 
 
<0.001 
 (c) 
International Physical Activity         
Questionnaire (IPAQ)  Low exercise   
                                       Moderate exercise                
                                       High exercise 
 
539 (24.1%) 
761 (34.1%) 
935 (41.8%) 
 
782 (30.2%) 
994 (38.4%) 
812 (31.4%) 
 
 
<0.001  
(c) 
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Grip Strength (kg)          
                                           
                                                      50-59                                
                                                      60-69 
                                                      70+ 
 
                                                     Total 
 
Mean (SD)              
 
28.5 (9.9)                
27.0 (8.9)                  
24.6 (8.6)                 
 
27.6 (9.5)                 
 
Mean (SD)              
 
26.8 (9.8)                
24.8 (8.8)                
21.9 (8.3)                 
 
24.7 (9.2)                
 
 
 
 
 
 
<0.001 
 (t) 
Gait Speed (m/second) 
 
                                                      50-59 
                                                      60-69 
                                                      70+ 
 
                                                      Total 
 
Mean (SD)              
 
1.4 (0.2)             
1.4 (0.2)            
1.3 (0.2)             
 
1.4 (0.2)             
Mean (SD)              
  
1.4 (0.2)            
1.3 (0.2)            
1.2 (0.2)            
 
1.3 (0.2)            
 
 
 
<0.001 
 (t) 
Note. Confounder variables missing <0.2% data in all cases; c= chi-squared test; t= t-test  
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Table 2: Multivariable Poisson regression model for A) development of multimorbidity in 
those with no multimorbidity at baseline and B) worsening multimorbidity in those with 
multimorbidity at baseline, over a two year period in adults aged 50 years and over (TILDA 
wave 1 &2)  
 No multimorbidity 
 
Relative risks and 
95% confidence 
intervals of those 
with no 
multimorbidity at 
baseline 
p-value Multimorbidity 
 
Relative risks and 
95% confidence 
intervals of those 
with multimorbidity 
at baseline 
p-value 
Age 
50-59  
60-69 
70 + 
 
 
1.00 
1.30 (1.11-1.52) 
1.35 (1.03-1.77) 
 
 
0.001 
0.027 
 
1.00 
1.20 (1.07-1.34) 
1.18 (1.01-1.37) 
 
 
0.002 
0.039 
Sex 
Male 
Female 
 
 
1.00 
1.05 (0.86-1.27) 
 
 
0.649 
 
1.00 
0.95(0.83-1.09) 
 
 
0.468 
Education 
Secondary  
Primary/ none  
Third/ higher  
 
 
1.00 
1.10 (0.93-1.30) 
0.96 (0.83-1.11) 
 
 
0.279 
0.582 
 
1.00 
0.94 (0.84-1.06) 
1.02 (0.91-1.14) 
 
 
0.314 
0.760 
Body Mass Index 
Normal: 18.5 -25  
& underweight:< 
18.5  
Overweight:25.1 -30  
Obese: >30.1  
 
 
 
 
1.00 
1.09 (0.92-1.28) 
1.26 (1.05-1.51) 
 
 
 
 
0.319 
0.011 
 
 
 
1.00 
0.96 (0.85-1.09) 
0.96 (0.84-1.10) 
 
 
 
 
0.542 
0.572 
Smoking      
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Non-smoker 
Smoker  
 
 
1.00 
1.08 (0.91-1.29) 
 
0.361 
1.00 
1.06 (0.92-1.22) 
 
0.457 
State Support 
No medical/General 
Practitioner  card  
Medical/ General 
Practitioner card  
 
 
 
1.00 
 
1.13 (0.97-1.31) 
 
 
 
 
0.130 
 
 
1.00 
 
1.20(1.07-1.34) 
 
 
 
 
0.002 
International 
Physical Activity 
Questionnaire 
(IPAQ) 
Low exercise  
Moderate  
High exercise 
 
 
 
 
1.00 
1.00 (0.85-1.19) 
1.04 (0.88-1.23) 
 
 
 
 
0.969 
0.640 
 
 
 
1.00 
0.94 (0.85-1.06) 
0.92 (0.81-1.04) 
 
 
 
 
0.309 
0.168 
Grip Strength (kg) 
 
 
0.98 (0.97-0.99) 
 
0.002 
 
0.990 (0.982-0.998)
 
 
0.014 
Gait Speed 
(m/second) 
 
 
0.67 (0.49-0.90) 
 
0.046 
 
0.61 (0.50-0.82) 
 
 
<0.001 
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